150 related articles for article (PubMed ID: 10430090)
1. Prognostic significance of the detection of circulating malignant cells by reverse transcriptase-polymerase chain reaction in long-term clinically disease-free melanoma patients.
Mellado B; Gutierrez L; Castel T; Colomer D; Fontanillas M; Castro J; Estapé J
Clin Cancer Res; 1999 Jul; 5(7):1843-8. PubMed ID: 10430090
[TBL] [Abstract][Full Text] [Related]
2. Prognostic role of circulating melanoma cells detected by reverse transcriptase-polymerase chain reaction for tyrosinase mRNA in patients with melanoma.
Visús C; Andres R; Mayordomo JI; Martinez-Lorenzo MJ; Murillo L; Sáez-Gutiérrez B; Diestre C; Marcos I; Astier P; Godino J; Carapeto-Marquez de Prado FJ; Larrad L; Tres A
Melanoma Res; 2007 Apr; 17(2):83-9. PubMed ID: 17496783
[TBL] [Abstract][Full Text] [Related]
3. Detection of circulating malignant cells by RT-PCR in long-term clinically disease-free I stage melanoma patients.
Baldi A; Dragonetti E; Battista T; Groeger AM; Esposito V; Baldi G; Santini D
Anticancer Res; 2000; 20(5C):3923-8. PubMed ID: 11268478
[TBL] [Abstract][Full Text] [Related]
4. Molecular staging in stage II and III melanoma patients and its effect on long-term survival.
Voit C; Kron M; Rademaker J; Schwürzer-Voit M; Sterry W; Weber L; Ozdemir C; Proebstle T; Keilholz U
J Clin Oncol; 2005 Feb; 23(6):1218-27. PubMed ID: 15718319
[TBL] [Abstract][Full Text] [Related]
5. The detection of tyrosinase mRNA in the peripheral blood of stage I melanoma patients is not of clinical relevance in predicting metastasis risk and survival.
Aubin F; Chtourou M; Teyssier JR; Laubriet A; Mougin CH; Blanc D; Humbert P
Melanoma Res; 2000 Apr; 10(2):113-8. PubMed ID: 10803711
[TBL] [Abstract][Full Text] [Related]
6. Molecular and biochemical testing in stage III melanoma: multimarker reverse transcriptase-polymerase chain reaction assay of lymph fluid after lymph node dissection and preoperative serum lactate dehydrogenase level.
Nowecki ZI; Rutkowski P; Kulik J; Siedlecki JA; Ruka W
Br J Dermatol; 2008 Sep; 159(3):597-605. PubMed ID: 18616789
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of microphthalmia-associated transcription factor and tyrosinase as markers for circulating tumor cells detection in patients with melanoma.
Samija I; Lukac J; Marić-Brozić J; Buljan M; Alajbeg I; Kovacević D; Situm M; Kusić Z
Melanoma Res; 2010 Aug; 20(4):293-302. PubMed ID: 20357686
[TBL] [Abstract][Full Text] [Related]
8. Correlation of positive RT-PCR for tyrosinase in peripheral blood of malignant melanoma patients with clinical stage, survival and other risk factors.
Proebstle TM; Jiang W; Högel J; Keilholz U; Weber L; Voit C
Br J Cancer; 2000 Jan; 82(1):118-23. PubMed ID: 10638977
[TBL] [Abstract][Full Text] [Related]
9. Serial follow-up and the prognostic significance of reverse transcriptase-polymerase chain reaction--staged sentinel lymph nodes from melanoma patients.
Kammula US; Ghossein R; Bhattacharya S; Coit DG
J Clin Oncol; 2004 Oct; 22(19):3989-96. PubMed ID: 15459222
[TBL] [Abstract][Full Text] [Related]
10. Molecular staging by multimarker reverse transcriptase-polymerase chain reaction assay of lymphatic drainage and blood from melanoma patients after lymph node dissection.
Rutkowski P; Nowecki ZI; Kulik J; Ruka W; Siedlecki JA
Melanoma Res; 2008 Aug; 18(4):246-52. PubMed ID: 18626308
[TBL] [Abstract][Full Text] [Related]
11. Detection of tyrosinase mRNA from the blood of melanoma patients.
Stevens GL; Scheer WD; Levine EA
Cancer Epidemiol Biomarkers Prev; 1996 Apr; 5(4):293-6. PubMed ID: 8722221
[TBL] [Abstract][Full Text] [Related]
12. Prognostic relevance of baseline and sequential peripheral blood tyrosinase expression in 200 consecutive advanced metastatic melanoma patients.
Quaglino P; Osella-Abate S; Cappello N; Ortoncelli M; Nardò T; Fierro MT; Cavallo F; Savoia P; Bernengo MG
Melanoma Res; 2007 Apr; 17(2):75-82. PubMed ID: 17496782
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of tyrosinase mRNA detected by nested RT-PCR in patients with malignant melanoma.
Glumac N; Snoj M; Hocevar M; Novakovic S
Neoplasma; 2006; 53(1):9-14. PubMed ID: 16416006
[TBL] [Abstract][Full Text] [Related]
14. Circulating tumor cells as prognostic factor for distant metastases and survival in patients with primary uveal melanoma.
Schuster R; Bechrakis NE; Stroux A; Busse A; Schmittel A; Scheibenbogen C; Thiel E; Foerster MH; Keilholz U
Clin Cancer Res; 2007 Feb; 13(4):1171-8. PubMed ID: 17317826
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of peripheral blood and bone marrow tyrosinase messenger RNA in malignant melanoma.
Ghossein RA; Coit D; Brennan M; Zhang ZF; Wang Y; Bhattacharya S; Houghton A; Rosai J
Clin Cancer Res; 1998 Feb; 4(2):419-28. PubMed ID: 9516931
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance and diagnostic value of protein S-100 and tyrosinase in patients with malignant melanoma.
Andrés R; Mayordomo JI; Visus C; Isla D; Godino J; Escudero P; Saenz A; Ortega E; Lastra R; Lambea J; Aguirre E; Elosegui L; Marcos I; Ruiz-Echarri M; Millastre E; Sáez-Gutierrez B; Asin L; Vidal MJ; Ferrer A; Giner A; Larrad L; Carapeto FJ; Tres A
Am J Clin Oncol; 2008 Aug; 31(4):335-9. PubMed ID: 18845991
[TBL] [Abstract][Full Text] [Related]
17. A meta-analysis of reverse transcriptase-polymerase chain reaction for tyrosinase mRNA as a marker for circulating tumor cells in cutaneous melanoma.
Tsao H; Nadiminti U; Sober AJ; Bigby M
Arch Dermatol; 2001 Mar; 137(3):325-30. PubMed ID: 11255333
[TBL] [Abstract][Full Text] [Related]
18. [Molecular diagnostic detection of circulating tumor cells and their prognostic implications].
Nakanishi H; Tatematsu M
Gan To Kagaku Ryoho; 1997 Feb; 24(3):257-65. PubMed ID: 9051125
[TBL] [Abstract][Full Text] [Related]
19. Molecular tumor markers in the blood: early prediction of disease outcome in melanoma patients treated with a melanoma vaccine.
Wascher RA; Morton DL; Kuo C; Elashoff RM; Wang HJ; Gerami M; Hoon DS
J Clin Oncol; 2003 Jul; 21(13):2558-63. PubMed ID: 12829676
[TBL] [Abstract][Full Text] [Related]
20. [Detection of circulating neoplastic cells by reverse transcriptase and polymerase chain reaction in melanoma].
Tessier MH; Denis MG; Lustenberger P; Dreno B
Ann Dermatol Venereol; 1997; 124(9):607-11. PubMed ID: 9739921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
